APA

Xu Z., Sharp P. P., Yao Y., Segal D., Ang C. H., Khaw S. L., Aubrey B. J., Gong J., Kelly G. L., Herold M. J., Strasser A., Roberts A. W., Alexander W. S., Burns C. J., Huang D. C. S. & Glaser S. P. (20170726). BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells. : Leukemia.

Chicago

Xu Z, Sharp P P, Yao Y, Segal D, Ang C H, Khaw S L, Aubrey B J, Gong J, Kelly G L, Herold M J, Strasser A, Roberts A W, Alexander W S, Burns C J, Huang D C S and Glaser S P. 20170726. BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells. : Leukemia.

Harvard

Xu Z., Sharp P. P., Yao Y., Segal D., Ang C. H., Khaw S. L., Aubrey B. J., Gong J., Kelly G. L., Herold M. J., Strasser A., Roberts A. W., Alexander W. S., Burns C. J., Huang D. C. S. and Glaser S. P. (20170726). BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells. : Leukemia.

MLA

Xu Z, Sharp P P, Yao Y, Segal D, Ang C H, Khaw S L, Aubrey B J, Gong J, Kelly G L, Herold M J, Strasser A, Roberts A W, Alexander W S, Burns C J, Huang D C S and Glaser S P. BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells. : Leukemia. 20170726.